Waters completes acquisition of BD's Biosciences unit, files S-3 for potential securities offering

Filed March 16, 2026 · Period ending March 16, 2026 · ~1 min read

Key Changes

• high

  Waters closed its acquisition of Becton, Dickinson's Biosciences and Diagnostic Solutions business on February 9, 2026. The company filed unaudited financial statements for the acquired unit covering periods through December 31, 2025.

  Item 9.01 verify on EDGAR →
• high

  Pro forma combined financials show what Waters would have looked like with the acquired business for the full year 2025, giving investors visibility into the merged company's financial profile.

  Item 9.01 verify on EDGAR →
• medium

  Waters plans to file an S-3 registration statement shortly after this 8-K, which could enable the company to issue debt or equity securities, potentially to finance the acquisition or for general corporate purposes.

  Item 9.01 verify on EDGAR →